Mary is a principal clinical scientist specialising in genomics at the C&S GLH, an honorary senior lecturer at Imperial College London, and a visiting lecturer at the University of Cambridge. She was awarded an MSc in Molecular Pathology in 2007 from Queen Mary University of London and a PhD in Genomic Medicine in 2016 from Imperial College London. She completed her first postdoc in 2019 at Imperial College London working on leukaemia MRD.
In addition to her clinical role, Mary takes pride in leadership, education and developing people and systems. She enjoys collaborative working, planning and setting up systematic solutions to complex problems. She finds satisfaction in having an impact, influencing and making a difference where she works.
Research interests are translational, focused on standardised implementation of genomic methodologies and point of care testing (POCT) technologies into routine clinical practice. In this regard, Mary is working in collaboration with the National Measurement Laboratory (NML), National Institute for Biological Standards and Control (NIBSC), the UK Accreditation Service (UKAS) in addition to multiple industry and pharma sponsors as part of the Knowledge Transfer Program (KTP) supported by the CSO's office at NHS England (NHSE)).
Mary is also a UKAS technical assessor for molecular genetics and bioinformatics, taking part in ensuring the delivery of high-quality genomic testing across the UK.
Other Interests include genomic education, scientific multi-media content development, data visualisation and scientific illustrations.
Areas of expertise
- Genomic Medicine/Precision Medicine
- Clinical Genomics
- Cancer Genomics
- Molecular Pathology
- Haemato-Oncology
- Minimal Residual Diseas (MRD)
- ISO 15189:2012 Med-Lab
- ISO 17025:2016 Medical Device
- ISO 13485:2020 Tissue Bank ISO/TS 20428:2017 Health Informatics</li>
- UKAS accreditation
- Bioinformatics
- Molecular Methodologies
- Molecular Diagnostics
- Genomic Testing
- Pharmacogenomics (PGx)